Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis-Reference-Cited by-同舟云学术

Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis

Published:2021-07-12 Issue:9 Volume:27 Page:1544-1552
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Vitanza Nicholas A.^ORCID,Johnson Adam J.^ORCID,Wilson Ashley L.,Brown Christopher,Yokoyama Jason K.,Künkele Annette^ORCID,Chang Cindy A.,Rawlings-Rhea Stephanie,Huang Wenjun^ORCID,Seidel Kristy,Albert Catherine M.,Pinto Navin^ORCID,Gust Juliane,Finn Laura S.,Ojemann Jeffrey G.,Wright Jason,Orentas Rimas J.,Baldwin Michael,Gardner Rebecca A.,Jensen Michael C.^ORCID,Park Julie R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-021-01404-8.pdf

Reference52 articles.

1. Gardner, R. A. et al. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood 129, 3322–3331 (2017).

2. Hudziak, R. M., Schlessinger, J. & Ullrich, A. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl Acad. Sci. USA 84, 7159–7163 (1987).

3. Shen, L. et al. The efficacy of third generation anti-HER2 chimeric antigen receptor T cells in combination with PD1 blockade against malignant glioblastoma cells. Oncol. Rep. 42, 1549–1557 (2019).

4. Ahmed, N. et al. HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial. JAMA Oncol. 3, 1094–1101 (2017).

5. Ahmed, N. et al. Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 67, 5957–5964 (2007).

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional and intratumoral adoptive T-cell therapy;Immuno-Oncology and Technology;2024-12

2. CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials;Cancer and Metastasis Reviews;2024-09-09

3. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

4. Spatiotemporal dynamics of tumor - CAR T-cell interaction following local administration in solid cancers;2024-08-30

5. CAR-based therapeutic targets in pediatric high-grade glioma;2024-08-28